112 related articles for article (PubMed ID: 12853698)
1. Marked decreases of total and immature reticulocytes in myelodysplastic syndrome among patients with pancytopenia.
Kabutomori O; Kanakura Y; Iwatani Y
Acta Haematol; 2003; 109(4):212-3. PubMed ID: 12853698
[No Abstract] [Full Text] [Related]
2. [The morphofunctional characteristics of the bone marrow erythroid cells in some forms of the myelodysplastic syndrome].
Sarycheva TG; Tsvetaeva NV; Kozinets GI
Ter Arkh; 1993; 65(7):52-4. PubMed ID: 8211781
[TBL] [Abstract][Full Text] [Related]
3. [Clinical, hematologic and developmental characteristics of myelodysplastic syndromes. Study of a group of patients with a long-term follow-up].
Di Giovanni S; Giallonardo P; Costa MP; Carducci P
Recenti Prog Med; 1987 Feb; 78(2):63-8. PubMed ID: 3473582
[No Abstract] [Full Text] [Related]
4. Marked and reproducible increase in trilineage blood cell counts by administration of granulocyte colony-stimulating factor in a patient with refractory anaemia with excess blasts in transformation.
Chiba S; Inamori K; Mitani K; Hirai H; Yazaki Y
Br J Haematol; 1994 Mar; 86(3):665-7. PubMed ID: 7519041
[TBL] [Abstract][Full Text] [Related]
5. [Myelodysplastic syndromes and refractory anemias with reference to the erythropoietic abnormalities].
Yoshida Y
Nihon Rinsho; 1991 Mar; 49(3):587-92. PubMed ID: 2041184
[No Abstract] [Full Text] [Related]
6. Reticulocyte maturity as an indicator for estimating qualitative abnormality of erythropoiesis.
Watanabe K; Kawai Y; Takeuchi K; Shimizu N; Iri H; Ikeda Y; Houwen B
J Clin Pathol; 1994 Aug; 47(8):736-9. PubMed ID: 7962628
[TBL] [Abstract][Full Text] [Related]
7. [Myelodysplastic syndromes].
Sainty D; Horschowski N; Fossat C; Sampol J
Ann Biol Clin (Paris); 1985; 43(6):821-30. PubMed ID: 3914223
[No Abstract] [Full Text] [Related]
8. Myelodysplastic syndrome with erythroid hypoplasia: a rare and distinct clincopathological entity--a report of two cases.
Kumar V; Dash S
Indian J Pathol Microbiol; 2005 Jan; 48(1):36-7. PubMed ID: 16758786
[TBL] [Abstract][Full Text] [Related]
9. Reticulocyte count with maturation fractions in pancytopenic evaluation by a fully automated counter.
Lin CK; Hsu HC; Chau WK; Jiang ML; Chiu CF
J Clin Lab Anal; 1993; 7(6):371-5. PubMed ID: 8277360
[TBL] [Abstract][Full Text] [Related]
10. [A 57-year-old patient with peripheral pancytopenia].
Fink M; Prenninger S; Sauer H
Internist (Berl); 1989 Mar; 30(3):210-3. PubMed ID: 2654063
[No Abstract] [Full Text] [Related]
11. Classification of the myelodysplastic syndromes.
Bennett JM
Clin Haematol; 1986 Nov; 15(4):909-23. PubMed ID: 3471370
[No Abstract] [Full Text] [Related]
12. Refractory cytopenia with multilineage dysplasia: further characterization of an 'unclassifiable' myelodysplastic syndrome.
Rosati S; Mick R; Xu F; Stonys E; Le Beau MM; Larson R; Vardiman JW
Leukemia; 1996 Jan; 10(1):20-6. PubMed ID: 8558932
[TBL] [Abstract][Full Text] [Related]
13. In vitro stimulation of erythropoiesis by stem cell factor alone in myelodysplastic syndrome patients with elevated endogenous erythropoietin serum levels.
Zwierzina H; Bammer T; Rollinger-Holzinger I; Herold M; Fenaux P; Nüssler V; Hoflehner E; Geissler D
Clin Cancer Res; 1996 Jun; 2(6):1031-8. PubMed ID: 9816264
[TBL] [Abstract][Full Text] [Related]
14. [Refractory anemia with excess of blasts (RAEB) with a high level of HbF that preceded apparent pancytopenia].
Matsuda A; Kusumoto S; Ito K; Yokoo H; Maruyama T; Jinnai I; Harano T; Watanabe K; Hirashima K
Rinsho Ketsueki; 1996 Jan; 37(1):60-4. PubMed ID: 8683869
[TBL] [Abstract][Full Text] [Related]
15. Ratio of bone marrow reticulocytes to peripheral corrected reticulocytes for evaluating ineffective erythropoiesis.
Choi JW
Ann Clin Lab Sci; 2006; 36(4):439-41. PubMed ID: 17127730
[No Abstract] [Full Text] [Related]
16. Leukocyte alkaline phosphatase score correlation with bone marrow blast percentage in myelodysplastic syndrome.
Lipshitz J; Limaye S; Patel D
Acta Haematol; 2010; 124(3):179-81. PubMed ID: 20962518
[No Abstract] [Full Text] [Related]
17. Recombinant human erythropoietin in patients with myelodysplastic syndromes.
Schouten HC; Vellenga E; van Rhenen DJ; de Wolf JT; Coppens PJ; Blijham GH
Leukemia; 1991 May; 5(5):432-6. PubMed ID: 2033964
[TBL] [Abstract][Full Text] [Related]
18. Recombinant human erythropoietin for treatment of myelodysplastic syndromes.
Rafanelli D; Grossi A; Longo G; Vannucchi AM; Bacci P; Ferrini PR
Leukemia; 1992 Apr; 6(4):323-7. PubMed ID: 1588794
[TBL] [Abstract][Full Text] [Related]
19. [Diagnosis, course and outcome of myelodysplasias].
Riauzova LIu; Soloveĭ DIa; Iavorkovskiĭ LI; Iavorkovskiĭ LL; Grinberg LIa
Gematol Transfuziol; 1988 Aug; 33(8):19-23. PubMed ID: 3192050
[No Abstract] [Full Text] [Related]
20. Myelodysplastic syndrome with prolonged reticulocyte survival mimicking hemolytic disease.
Sher GD; Pinkerton PH; Ali MA; Senn JS
Am J Clin Pathol; 1994 Feb; 101(2):149-53. PubMed ID: 8116568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
